approval
saveTOPIRAMATE — FDA approval
community read0 votes
Sponsor: ASCENT PHARMS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMar 6, 2026 · 219d ago
- approvalTOPIRAMATE — FDA approvalJan 27, 2026 · 257d ago
- approvalTOPIRAMATE — FDA approvalJan 18, 2026 · 266d ago
- approvalTOPIRAMATE — FDA approvalDec 4, 2025 · 311d ago
- approvalTOPIRAMATE — FDA approvalOct 7, 2025 · 369d ago
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMar 12, 2025 · 578d ago
- approvalTOPIRAMATE — FDA approvalJul 16, 2024 · 817d ago
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMay 17, 2024 · 877d ago
same company · ±60 days · 6
- approvalBUPRENORPHINE HYDROCHLORIDE: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalJan 21, 2026
- approvalMETHADONE HYDROCHLORIDE: METHADONE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalMETHADONE HYDROCHLORIDE: METHADONE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 22, 2025
- approvalHYDROMORPHONE HYDROCHLORIDE: HYDROMORPHONE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalacetaminophen ER: OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 22, 2025
comments(0)
5-min edit window · permanent after that